Document is current
Any future updates will be listed below
-
Authors
Seidel, Sabine http://orcid.org/0000-0002-1671-3297
Wehner, Tim
Miller, Dorothea
Wellmer, Jörg
Schlegel, Uwe
Grönheit, Wenke
- License Information
-
More Information
Article History
Received: 17 June 2022
Accepted: 13 July 2022
First Online: 5 September 2022
Declarations
:
: As this was a review article no ethics approval was applied for and as no patient data was analyzed for this review article consent to participate was not necessary.
: The manuscript does not contain any individual person’s data.
: T.W. has received of honoraria or consultation fees Eisai, UCB, GW, Angelini, Precisis and is a stock shareholder of Amgen. J.W. has received speaker fees from UCB, Eisai, Bial, GW pharmaceuticals, and Desitin. U.S. received speaker’s honoraria from Medac, GSK and Novartis. W.G. has received speaker´s honoraria, travel or accommodation payment fees from UCB, Eisei, Bial and Desitin. The other authors declare no competing interests.
